课题基金 / 基金详情

EAGER: Biomanufacturing: Multi-scale high-aspect ratio structures (HARS) for constructing dynamic 2D and 3D cellular bioreactors

EAGER: Biomanufacturing: Multi-scale high-aspect ratio structures (HARS) for constructing dynamic 2D and 3D cellular bioreactors
EAGER:生物制造:用于构建动态 2D 和 3D 细胞生物反应器的多尺度高纵横比结构 (HARS)
批准号:
1547693
负责人:
Mark DeCoster
金额:
$30.0万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-15 至 2019-08-31

项目摘要

项目成果

Mark DeCoster的其他基金

相似基金

相关文献

中文摘要
翻译
PI:DeCoster,Mark A. 提案编号:1547693一种类型的生物制造涉及将细胞在二维(2D)和三维(3D)中放置在一起。 为了更好地了解健康和患病组织中发生的情况,必须了解细胞的生长以及细胞死亡。 就像修剪树枝而不杀死它一样,该项目的研究人员将使用一种称为细胞凋亡的受控自然过程来修剪2D和3D环境中的细胞群,以改善整体结构的功能。 这些研究可以增强我们对如何控制正常细胞形成组织以及如何控制癌症等疾病过程的理解。 该项目中待研究的细胞容器将包括使用3D打印机生成的生物反应器。该项目的技术组件旨在解决在2D和3D环境中生成和塑造细胞组件的挑战。 该项目旨在了解正常细胞和癌细胞的生长过程,目标是实现更好的生物制造策略并深入了解肿瘤生长。 除了生长之外,EAGER奖的研究人员还将使用两种类型的高纵横比结构(HARS)对细胞施加凋亡刺激,以受控的方式修剪细胞。 为了便于成像到更厚(0.5 mm)的3D细胞组件在这个项目中,梯度折射率(GRIN)透镜结合多光子显微镜将被使用。 该项目中使用的HARS材料包括一种中空的、不可降解的埃洛石和一种新型的、可生物降解的含铜生物复合材料。 这两种HARS材料的尺寸都从直径的纳米尺寸扩展到长度的微米尺寸。 在该项目中进行的实验将利用使用3D打印机生成的生物反应器,生物反应器的功能输出将包括使用快速生长的胶质瘤细胞系和生长较慢(正常)的星形胶质细胞原代培养模型检测谷氨酸和pH动态,以比较细胞输出与细胞凋亡修剪过程前后的生长。 为了更好地近似脑中的动态过程,还将添加小胶质细胞以模拟细胞凋亡后的恢复。 为该项目生成的3D打印生物反应器的铸造厂将以生物反应器图像,.stl文件和动画的形式建立,并将进行测试,以与市售的毫流体设备集成,以检测例如生物反应器中随时间发生的化学变化。 该项目的结果预计将影响未来的生物制造战略和教育材料,考虑到3D打印技术和设计软件的日益可用性。
英文摘要
PI: DeCoster, Mark A. Proposal Number: 1547693One type of Biomanufacturing involves placing cells together in both two dimensions (2D) and three dimensions (3D). To better approximate what happens in the body in both healthy and diseased tissues, the growth of cells, as well as cell death must be understood. Much like pruning the limbs of a tree without killing it, the investigators of this project will use a controlled, natural process called apoptosis to prune groups of cells in both 2D and 3D environments to improve the function of the overall construct. These studies could enhance our understanding of how to control normal cell formations into tissues and how to control disease processes such as cancer. The containers for the cells to be studied in this project will include bioreactors generated using 3D printers. The technological components of this project seek to address the challenges of generating and shaping assemblies of cells in both 2D and 3D environments. The project aims to understand the growth processes of both normal and cancer cells, with the goal of achieving better biomanufacturing strategies and insight into tumor growth. Beyond just growth, the investigators of this EAGER award will also apply apoptotic stimuli to cells using two types of high-aspect ratio structures (HARS), to prune away cells in a controlled manner. To facilitate imaging into thicker (0.5 mm) 3D cell assemblies in this project, gradient index (GRIN) lenses combined with multi-photon microscopy will be used. The HARS materials used in this project include a hollow, non-degradable halloysite, and a novel, biodegradable biocomposite containing copper. Both HARS materials scale from the nano-dimension in diameter to the micro-dimension in length. The experiments carried out in this project will utilize bioreactors generated using 3D printers and functional outputs from the bioreactors will include detection of glutamate and pH dynamics using a fast-growing glioma cell line and slower growing (normal) astrocyte primary culture model to compare cellular outputs with growth before and after the pruning process of apoptosis. To better approximate dynamic processes in the brain, microglia will also be added to model recovery after apoptosis. A foundry of 3D printed bioreactors generated for the project will be established in the form of bioreactor images, .stl files, and animations, and will be tested for integration with commercially available millifluidic devices to detect, for example, chemical changes occurring in the bioreactors over time. Results from this project are anticipated to impact future biomanufacturing strategies and educational materials considering the increasing availability of 3D-printing technology and design software.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
I-Corps: CELLDIPS-Cell Discovery Platforms for commercial and educational applications
  • 批准号:
    1463098
  • 项目类别:
    Standard Grant
  • 资助金额:
    $5.0万
  • 财政年份:
    2014
  • 负责人:
    Mark DeCoster
  • 依托单位:
SHF: Small: Collaborative Research: Computing with cells-the neuron case
  • 批准号:
    1116707
  • 项目类别:
    Standard Grant
  • 资助金额:
    $20.0万
  • 财政年份:
    2011
  • 负责人:
    Mark DeCoster
  • 依托单位:
海外基金